L R Gooding

7.5k citations
86 papers · 6.2k indexed · 1 hit paper · h-index 43
Topics
Virus-based gene therapy research (55 papers)CAR-T cell therapy research (23 papers)RNA Interference and Gene Delivery (13 papers)

In The Last Decade

L R Gooding

86 papers receiving 6.0k citations

Hit Papers

Tumor necrosis factor can induce both apoptic and necroti...19882026200020131988250500750

Peers

L R Gooding
Comparison fields: 5 of 118
  • Molecular Biology 3.0k
  • Genetics 2.9k
  • Immunology 2.0k
  • Oncology 1.4k
  • Epidemiology 1.1k
Replace Philip E. Branton with:
Philip E. Branton Canada
Paul L. Hermonat United States
Andrea Gambotto United States
Thomas Dobner Germany
Susan R. Ross United States
Andrew J. Dorner United States
Lindsey Moffat United Kingdom
Steven Kessler United States
Nicola La Monica Italy
Amos Panet Israel
L R Gooding relative to Philip E. Branton Canada Philip E. Branton's profile →
Citations per field
00.5×1.7×
Philip E. Branton · 1×
Citations per year

Countries citing papers authored by L R Gooding

Since Specialization
Citations

This map shows the geographic impact of L R Gooding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L R Gooding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L R Gooding more than expected).

Fields of papers citing papers by L R Gooding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L R Gooding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L R Gooding. The network helps show where L R Gooding may publish in the future.

Co-authorship network of co-authors of L R Gooding

This figure shows the co-authorship network connecting the top 25 collaborators of L R Gooding. A scholar is included among the top collaborators of L R Gooding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L R Gooding. L R Gooding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 10
3 10
4 161
5 24
6 8
7 42
8 26
9 113
10 9
11 89
12 55
13 338
14 198
15
Sensitivity to tumour necrosis factor-mediated cytolysis is unrelated to manganous superoxide dismutase messenger RNA levels among transformed mouse fibroblasts.
12
16
Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor.
46
17 1
18
Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis.breakdown →
773
19 17
20 207

About L R Gooding

L R Gooding is a scholar working on Genetics, Immunology and Oncology, having authored 86 papers that have together received 6.2k indexed citations. Recurring topics across this work include Virus-based gene therapy research (55 papers), CAR-T cell therapy research (23 papers) and RNA Interference and Gene Delivery (13 papers). The work is most often cited by research in Genetics (2.9k citations), Immunology (2.0k citations) and Oncology (1.4k citations). L R Gooding has collaborated with scholars based in United States, Sweden and Switzerland. Frequent co-authors include William S.M. Wold, Scott M. Laster, John G. Wood, Penelope J. Duerksen-Hughes, Ann E. Tollefson, Charlie Garnett‐Benson, Eileen White, Peter Sabbatini, Dean D. Erdman and Carl F. Ware. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026